BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 18322168)

  • 1. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo.
    Idoyaga J; Cheong C; Suda K; Suda N; Kim JY; Lee H; Park CG; Steinman RM
    J Immunol; 2008 Mar; 180(6):3647-50. PubMed ID: 18322168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.
    Flacher V; Tripp CH; Haid B; Kissenpfennig A; Malissen B; Stoitzner P; Idoyaga J; Romani N
    J Immunol; 2012 Mar; 188(5):2146-55. PubMed ID: 22291181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
    Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
    J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
    J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.
    Idoyaga J; Lubkin A; Fiorese C; Lahoud MH; Caminschi I; Huang Y; Rodriguez A; Clausen BE; Park CG; Trumpfheller C; Steinman RM
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2384-9. PubMed ID: 21262813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of monoclonal antibodies that recognize the extracellular domain of mouse langerin/CD207.
    Cheong C; Idoyaga J; Do Y; Pack M; Park SH; Lee H; Kang YS; Choi JH; Kim JY; Bonito A; Inaba K; Yamazaki S; Steinman RM; Park CG
    J Immunol Methods; 2007 Jul; 324(1-2):48-62. PubMed ID: 17553520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function.
    Kissenpfennig A; Aït-Yahia S; Clair-Moninot V; Stössel H; Badell E; Bordat Y; Pooley JL; Lang T; Prina E; Coste I; Gresser O; Renno T; Winter N; Milon G; Shortman K; Romani N; Lebecque S; Malissen B; Saeland S; Douillard P
    Mol Cell Biol; 2005 Jan; 25(1):88-99. PubMed ID: 15601833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
    Adams EW; Ratner DM; Seeberger PH; Hacohen N
    Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells.
    Tagliani E; Guermonprez P; Sepúlveda J; López-Bravo M; Ardavín C; Amigorena S; Benvenuti F; Burrone OR
    J Immunol; 2008 Mar; 180(5):3201-9. PubMed ID: 18292544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen.
    Idoyaga J; Suda N; Suda K; Park CG; Steinman RM
    Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1524-9. PubMed ID: 19168629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains.
    Flacher V; Douillard P; Aït-Yahia S; Stoitzner P; Clair-Moninot V; Romani N; Saeland S
    Immunology; 2008 Mar; 123(3):339-47. PubMed ID: 18217955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.
    Pooley JL; Heath WR; Shortman K
    J Immunol; 2001 May; 166(9):5327-30. PubMed ID: 11313367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules.
    Ramakrishna V; Treml JF; Vitale L; Connolly JE; O'Neill T; Smith PA; Jones CL; He LZ; Goldstein J; Wallace PK; Keler T; Endres MJ
    J Immunol; 2004 Mar; 172(5):2845-52. PubMed ID: 14978085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
    Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P
    Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.
    Kamphorst AO; Guermonprez P; Dudziak D; Nussenzweig MC
    J Immunol; 2010 Sep; 185(6):3426-35. PubMed ID: 20729332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.
    Birkholz K; Schwenkert M; Kellner C; Gross S; Fey G; Schuler-Thurner B; Schuler G; Schaft N; Dörrie J
    Blood; 2010 Sep; 116(13):2277-85. PubMed ID: 20566893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH γ-1 class switching in response to gene gun vaccines.
    Stoecklinger A; Eticha TD; Mesdaghi M; Kissenpfennig A; Malissen B; Thalhamer J; Hammerl P
    J Immunol; 2011 Feb; 186(3):1377-83. PubMed ID: 21187444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Batf3-independent langerin- CX3CR1- CD8α+ splenic DCs represent a precursor for classical cross-presenting CD8α+ DCs.
    Petersen TR; Knight DA; Tang CW; Osmond TL; Hermans IF
    J Leukoc Biol; 2014 Dec; 96(6):1001-10. PubMed ID: 25170118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria for dendritic cell receptor selection for efficient antibody-targeted vaccination.
    Reuter A; Panozza SE; Macri C; Dumont C; Li J; Liu H; Segura E; Vega-Ramos J; Gupta N; Caminschi I; Villadangos JA; Johnston AP; Mintern JD
    J Immunol; 2015 Mar; 194(6):2696-705. PubMed ID: 25653426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens.
    Qiu CH; Miyake Y; Kaise H; Kitamura H; Ohara O; Tanaka M
    J Immunol; 2009 Apr; 182(7):4127-36. PubMed ID: 19299710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.